In ASCVD, 81 mg and 325 mg of aspirin did not differ for CV or bleeding events
- 1 October 2021
- journal article
- editorial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (10), JC118
- https://doi.org/10.7326/acpj202110190-118
Abstract
Source Citation Jones WS, Mulder H, Wruck LM, et al. Comparative effectiveness of aspirin dosing in cardiovascular disease. N Engl J Med. 2021;384:1981-90. 33999548 Clinical Impact Ratings GIM/FP/GP: 5 out of 7 Cardiology: 6 out of 7 Neurology: 5 out of 7This publication has 1 reference indexed in Scilit:
- Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled TrialsThe American Journal of Cardiology, 2005